1 link tagged with all of: openai + drug development + orchestra bio
Click any tag below to further narrow down your results
Links
OpenAI has bought Orchestra Bio, a platform that helps biopharma teams coordinate drug programs across departments and partners. The plan is to combine it with Rosalind, OpenAI's life sciences AI, so agents can track studies and flag problems before they stall a program.
- Drug development typically takes 10 to 15 years from target discovery to US regulatory approval, and teams often juggle disconnected systems across internal departments and outside partners.
- Orchestra's agents monitor studies and timelines, so when something breaks, like a failed manufacturing batch that delays a clinical trial, they show which activities are affected and compare ways to respond.
- The longer goal is AI that helps with the whole process, from exploring ideas and designing experiments to interpreting results and coordinating the work.